$107 Million is the total value of Copernicus Capital Management, LLC's 17 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 52.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DVA | Buy | DAVITA INC | $12,636,000 | +32.3% | 176,403 | +28.3% | 11.86% | +71.2% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $12,560,000 | +9.0% | 21,881 | -9.1% | 11.79% | +41.1% |
| SYK | Sell | STRYKER CORP | $12,376,000 | +4.4% | 69,652 | -0.8% | 11.62% | +35.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $12,125,000 | +7.4% | 62,907 | -5.3% | 11.38% | +38.9% |
| CVS | Buy | CVS HEALTH CORP | $11,022,000 | +26.3% | 140,009 | +3.3% | 10.35% | +63.4% |
| NUVA | Sell | NUVASIVE INC | $6,190,000 | +35.1% | 87,205 | -0.8% | 5.81% | +74.7% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $5,666,000 | -32.9% | 32,544 | -43.9% | 5.32% | -13.2% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $5,545,000 | -4.8% | 458,630 | +23.0% | 5.21% | +23.2% |
| ZTS | Sell | ZOETIS INCcl a | $5,078,000 | +6.6% | 55,460 | -0.8% | 4.77% | +37.9% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $4,932,000 | -57.2% | 20,206 | -63.7% | 4.63% | -44.6% |
| HSIC | Sell | SCHEIN HENRY INC | $4,639,000 | +16.1% | 54,563 | -0.8% | 4.36% | +50.2% |
| PDCO | New | PATTERSON COMPANIES INC | $4,157,000 | – | 170,000 | +100.0% | 3.90% | – |
| ILMN | Sell | ILLUMINA INC | $3,598,000 | -68.7% | 9,802 | -76.2% | 3.38% | -59.5% |
| CDNA | New | CAREDX INC | $1,875,000 | – | 65,000 | +100.0% | 1.76% | – |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $1,779,000 | – | 51,000 | +100.0% | 1.67% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $1,355,000 | -75.8% | 42,822 | -70.3% | 1.27% | -68.8% |
| New | AMICUS THERAPEUTICS INCcall | $967,000 | – | 80,000 | +100.0% | 0.91% | – | |
| HUM | Exit | HUMANA INC | $0 | – | -10,000 | -100.0% | -2.16% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -36,737 | -100.0% | -2.61% | – |
| IART | Exit | INTEGRA LIFESCIENCES HLDGS C | $0 | – | -63,000 | -100.0% | -2.94% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -286,797 | -100.0% | -3.49% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -141,345 | -100.0% | -4.66% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -169,511 | -100.0% | -4.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.